064400:KRXLG CNS Analysis

LG CNS is trading just below its 20‑day SMA (≈68,510) and marginally above its 50‑day SMA, indicating a near‑term price squeeze while the 200‑day SMA remains supportive. The MACD line sits in bearish territory (-841) with a negative histogram, suggesting short‑term momentum weakness, yet the overall trend is flagged as bullish and the RSI hovers around a neutral 50.6, implying no immediate over‑bought or over‑sold condition. A remarkably low beta of 0.29 points to limited market‑wide volatility, but the 30‑day price swing of over 70% signals heightened intra‑period volatility. Fundamentally, the company posted 5.8% revenue growth, maintains a solid free cash flow generation (~29.5 bn KRW) and a modest debt‑to‑equity ratio of 23.8, supporting its 2.72% dividend yield. The forward P/E of 12.7 is well below the industry average of 33.7, highlighting relative valuation attractiveness despite a DCF‑derived fair value (≈61,700 KRW) that sits beneath the current price. Combined with a sustainable payout ratio of ~18% and strategic positioning in cloud, AI and digital transformation, the stock presents a balanced mix of growth potential and income stability.